Research and Collaboration Arrangements (Tables)

3 Months Ended

Mar. 31, 2022

Research And Collaboration Arrangements [Abstract]

Summary of Collaboration and License Revenue

Collaboration and license revenue for each period was as follows (in thousands):

	Three Months Ended March 31,
	2022		2021
uniQure	$	1,192	$	392
Roche		—		1,605
CFF		27		3
Total revenue	$	1,219	$	2,000

Summary of Deferred Revenue

Deferred revenue is summarized as follows (in thousands):

	March 31, 2022		December 31, 2021
uniQure	$	2,469	$	3,661
CFF		1,401		1,429
Total deferred revenue	$	3,870	$	5,090